CAD 0.12
(-17.86%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 250.32 Thousand CAD | 31.97% |
2022 | 189.67 Thousand CAD | 775.3% |
2021 | 21.67 Thousand CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - CAD | 0.0% |
2024 Q1 | - CAD | 0.0% |
2024 Q3 | - CAD | 0.0% |
2023 Q4 | - CAD | 0.0% |
2023 FY | 250.32 Thousand CAD | 31.97% |
2023 Q1 | 120 Thousand CAD | 21.3% |
2023 Q3 | - CAD | -100.0% |
2023 Q2 | 130.32 Thousand CAD | 8.6% |
2022 Q4 | 98.92 Thousand CAD | 41.6% |
2022 FY | 189.67 Thousand CAD | 775.3% |
2022 Q3 | 69.86 Thousand CAD | 482.98% |
2022 Q2 | 11.98 Thousand CAD | 34.64% |
2022 Q1 | 8901.00 CAD | -37.82% |
2021 Q1 | - CAD | 0.0% |
2021 Q2 | 1457.00 CAD | 0.0% |
2021 Q3 | 5899.00 CAD | 304.87% |
2021 Q4 | 14.31 Thousand CAD | 142.65% |
2021 FY | 21.67 Thousand CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | - CAD | -Infinity% |
Asep Medical Holdings Inc | 21.14 Thousand CAD | -1084.12% |
BetterLife Pharma Inc. | - CAD | -Infinity% |
BioVaxys Technology Corp. | - CAD | -Infinity% |
ChitogenX Inc. | - CAD | -Infinity% |
Rapid Dose Therapeutics Corp. | 1.02 Million CAD | 75.469% |
Defence Therapeutics Inc. | - CAD | -Infinity% |
Gemina Laboratories Ltd. | - CAD | -Infinity% |
Glow Lifetech Corp. | 43.93 Thousand CAD | -469.809% |
Lexston Life Sciences Corp. | - CAD | -Infinity% |
Pharmala Biotech Holdings Inc. | 532 Thousand CAD | 52.947% |
Doseology Sciences Inc. | 98.52 Thousand CAD | -154.078% |
MYND Life Sciences Inc. | - CAD | -Infinity% |
Nova Mentis Life Science Corp. | 28.34 Thousand CAD | -783.098% |
PharmaTher Holdings Ltd. | - CAD | -Infinity% |
PreveCeutical Medical Inc. | - CAD | -Infinity% |
Telescope Innovations Corp. | 595.39 Thousand CAD | 57.957% |